Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock $0.001 par value
-
Shares outstanding
-
28M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
500
-
Shares change
-
-13.8K
-
Total reported value, excl. options
-
$1K
-
Value change
-
-$16K
-
Number of sells
-
-2
-
Price
-
$2.00
Significant Holders of GEOVAX LABS, INC. - Common Stock $0.001 par value (BLCM) as of Q3 2022
3 filings reported holding BLCM - GEOVAX LABS, INC. - Common Stock $0.001 par value as of Q3 2022.
GEOVAX LABS, INC. - Common Stock $0.001 par value (BLCM) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 500 shares
of 28M outstanding shares and own 0% of the company stock.
Largest 10 shareholders include Orion Capital Management LLC (500 shares), CITADEL ADVISORS LLC (0 shares), UBS Group AG (0 shares), Ikarian Capital, LLC (448K shares), VANGUARD GROUP INC (365K shares), Long Focus Capital Management, LLC (328K shares), BAKER BROS. ADVISORS LP (249K shares), BlackRock Inc. (76.1K shares), GEODE CAPITAL MANAGEMENT, LLC (72.9K shares), and BOXER CAPITAL, LLC (57K shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.